Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Methylation of the Wnt Signaling Antagonist, Wnt Inhibitory Factor 1 and Dickkopf-1 Genes in Acute Myeloid Leukemia at the Time of Diagnosis

Ali Ghasemi 1 , * , Abbas Ghotaslou 1 , Mohsen Mohammadi 2 , Sadegh Abbasian 1 and Kazem Ghaffari 3
Authors Information
1 Department of Hematology, Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Biotechnology, Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Biology, Faculty of Allied Medical Sciences, Arak University of Medical Sciences, Arak, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: January 31, 2016, 18 (1); e5874
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: August 18, 2014
  • Accepted: November 25, 2014
  • DOI: 10.17795/zjrms-5874

To Cite: Ghasemi A, Ghotaslou A, Mohammadi M, Abbasian S, Ghaffari K. Methylation of the Wnt Signaling Antagonist, Wnt Inhibitory Factor 1 and Dickkopf-1 Genes in Acute Myeloid Leukemia at the Time of Diagnosis, Zahedan J Res Med Sci. 2016 ; 18(1):e5874. doi: 10.17795/zjrms-5874.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999; 341(14): 1051-62[DOI][PubMed]
  • 2. Galm O, Herman JG. Methylation-specific polymerase chain reaction. Methods Mol Med. 2005; 113: 279-91[DOI][PubMed]
  • 3. Gilbert J, Gore SD, Herman JG, Carducci MA. The clinical application of targeting cancer through histone acetylation and hypomethylation. Clin Cancer Res. 2004; 10(14): 4589-96[DOI][PubMed]
  • 4. Claus R, Almstedt M, Lubbert M. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol. 2005; 32(5): 511-20[DOI][PubMed]
  • 5. Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2007; 109(1): 52-7[DOI][PubMed]
  • 6. Plimack ER, Kantarjian HM, Issa JP. Decitabine and its role in the treatment of hematopoietic malignancies. Leuk Lymphoma. 2007; 48(8): 1472-81[DOI][PubMed]
  • 7. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006; 25(29): 4116-21[DOI][PubMed]
  • 8. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents Vol. VIII. 2002;
  • 9. Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman JG, et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol. 2008; 142(5): 745-53[DOI][PubMed]
  • 10. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008; 8(5): 387-98[DOI][PubMed]
  • 11. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004; 351(7): 657-67[DOI][PubMed]
  • 12. Paul S, Dey A. Wnt signaling and cancer development: therapeutic implication. Neoplasma. 2008; 55(3): 165-76[PubMed]
  • 13. Jones SE, Jomary C. Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays. 2002; 24(9): 811-20[DOI][PubMed]
  • 14. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781-810[DOI][PubMed]
  • 15. Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, et al. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res. 2005; 65(16): 7081-5[DOI][PubMed]
  • 16. Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci. 2008; 121: 737-46[DOI][PubMed]
  • 17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215[PubMed]
  • 18. Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, Yang PY, et al. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer. 2007; 7: 126[DOI][PubMed]
  • 19. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer. 2001; 1(1): 55-67[DOI][PubMed]
  • 20. Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia. 2007; 21(8): 1638-47[DOI][PubMed]
  • 21. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429(6990): 457-63[DOI][PubMed]
  • 22. Nakamoto D, Yamamoto N, Takagi R, Katakura A, Mizoe JE, Shibahara T. Detection of microsatellite alterations in plasma DNA of malignant mucosal melanoma using whole genome amplification. Bull Tokyo Dent Coll. 2008; 49(2): 77-87[PubMed]
  • 23. Ghasemi A. , Nadali F. , Chahardouli B, Alizad Ghandforosh N, Ghavam Zadeh A, Rostami S. Study of correlation between SFRP-1 and SFRP-2 hypermethylation with relapse, complete remission, genetic mutations of FLT3-ITD and NPM1 and immunophenotypes of leukemic cells in patients with de novo acute myeloblastic leukemia. J Hematol. 2014; 3(2): 34-42
  • 24. Yu J, Tao Q, Cheng YY, Lee KY, Ng SS, Cheung KF, et al. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer. 2009; 115(1): 49-60[DOI][PubMed]
  • 25. Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, et al. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther. 2012; 11(10): 2105-15[DOI][PubMed]
  • 26. Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R, et al. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol. 2004; 171(3): 1314-8[DOI][PubMed]
  • 27. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M, et al. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol. 2001; 19(1): 117-21[PubMed]
  • 28. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, Barrios M, et al. Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia. Br J Cancer. 2004; 91(4): 707-13[DOI][PubMed]
  • 29. Suzuki R, Onizuka M, Kojima M, Shimada M, Fukagawa S, Tsuboi K, et al. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia. Br J Haematol. 2007; 138(5): 624-31[DOI][PubMed]
  • 30. Griffiths EA, Gore SD, Hooker C, McDevitt MA, Karp JE, Smith BD, et al. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation. Leuk Lymphoma. 2010; 51(9): 1711-9[DOI][PubMed]
  • 31. Hou HA, Kuo YY, Liu CY, Lee MC, Tang JL, Chen CY, et al. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia. Br J Cancer. 2011; 105(12): 1927-33[DOI][PubMed]
  • 32. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol. 2004; 50(3): 197-222[DOI][PubMed]
  • 33. Chim CS, Chan WW, Pang A, Kwong YL. Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor. Leukemia. 2006; 20(5): 907-9[DOI][PubMed]
  • 34. Valencia A, Roman-Gomez J, Cervera J, Such E, Barragan E, Bolufer P, et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia. 2009; 23(9): 1658-66[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments